Elecsys BRAHMS PCT helps personalise your sepsis patient management by providing reliable real-time clinical decision support data about the source of a suspected infection, disease severity & progression, and response to treatment.
PCT levels increase as sepsis progresses and severity increases, allowing the differentiation of patients with SIRS, sepsis, severe sepsis or septic shock. PCT is a biomarker with high specificity for an inflammatory response to a bacterial infection. PCT concentrations in the blood can aid clinicians in the detection of clinically relevant bacterial infections. PCT is considered a prognostic marker to support outcome prediction in sepsis patients. PCT can be used for decision of antibiotic treatment necessity and to monitor treatment success in LRTI.1,2,3,4
Sepsis is life threatening organ dysfunction caused by a dysregulated host response to infection.5,6,7 Sepsis and septic shock are major healthcare problems, with more than 1 in 1000 people in developed countries suffering from sepsis each year.8 Early identification and appropriate management in the initial hours after sepsis develops improves outcomes.9
Elecsys BRAHMS PCT helps to improve your sepsis patient management by providing reliable realtime clinical decision support data about a suspected infection, disease severity, and response to treatment.
- Low sample volume
- Broad measuring range
- Short total assay time
- Excellent inter- and intra-assay CV (coefficient of variation)
- Available on all cobas e analyzers